Evidence map›Paper›PMID 40374547›Full record

ArticleJournal of microbiology and biotechnology2025

Effect of

Tae-Ho Kim, Dae Eung Kim, Hoon-Min Lee, Mi-Jung Kang, Jung Hwa Kim, Jungmok You, Mi Kyeong Lee, Yeon-Gu Kim

Abstract read
In one paragraph

Article in Journal of microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tae-Ho KimBiotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
Dae Eung KimCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Hoon-Min LeeBiotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
Mi-Jung KangBiotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
Jung Hwa KimDepartment of R&D, Boditech Med Inc., Chuncheon 24398, Republic of Korea.
Jungmok YouDepartment of Convergent Biotechnology & Advanced Materials Science, Graduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin-si 17104, Republic of Korea.
Mi Kyeong LeeCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Yeon-Gu KimBiotherapeutics Translational Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serum-free suspension culture for hybridomas is one of the important key steps for efficient diagnostic antibody production while maintaining protein quality and function. Based on the importance of

Indexed as

Antibodies, MonoclonalAntibody AffinityHybridomasPolysaccharidesAnimalsCulture Media, Serum-FreeGlycosylationHumansMiceProtein BindingTunicamycinAntibodies, MonoclonalCulture Media, Serum-FreePolysaccharidesTunicamycinbinding affinitydiagnostic antibodyglycosylationHybridomassuspension culture

Identifiers

PMID40374547
PMCPMC12099623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.